Bajaj Healthcare profitability ratios

Per cent unless marked ×
Tap a line for its trendLast 12Mto Sep 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
Returns
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
3.2%3.2%10.6%−25.9%12.4%
1.8%1.8%4.9%−10.1%5.3%
13.3%13.3%11.5%11.4%17.1%
8.1%7.8%7.4%6.9%7.7%
Margins
17.3%17.2%15.2%16.1%15.9%
12.7%12.7%10.1%10.3%11.8%
—33.3%8.5%15.4%—
5.1%4.7%8.5%−3.5%8.6%
3.1%2.6%7.3%−17.7%6.4%
2.4%2.4%1.9%13.1%−17.2%
Additional
25.2%26.3%6.7%14.1%26.1%
—20.0%7.0%−3.3%9.6%
3.2%2.5%9.9%−26.8%11.2%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

BAJAJHCARE₹314.45

Bajaj Healthcare Limited

· Pharma & Health
₹ CrorePeersTHEMISMEDLINCOLNWANBURYSIGACHIAHCLANUHPHRAMRUTANJANMcap ₹1,059 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/09/2026
Returns
Return on Common Equity12.36-25.9410.613.163.16
Return on Assets5.30-10.064.941.801.80
Return on Capital Employed17.0811.3811.4713.2713.27
Return on Invested Capital7.696.877.417.818.07
Margins
EBITDA Margin15.8716.1115.1917.1517.28
Operating Margin11.8110.2810.0512.6512.65
Incremental Operating Margin—15.438.4733.26—
Pretax Margin8.65-3.528.484.735.09
Net Income Margin6.39-17.707.282.583.14
FCF Margin-17.2213.101.862.412.41
Additional
Effective Tax Rate26.1014.096.6926.3225.20
Dvd Payout Ratio9.62-3.296.9920.03—
Sustainable Growth Rate11.17-26.799.872.533.16
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.